OTCMKTS:NBHGF

Nobel Biocare (NBHGF) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$18.25
$18.25
50-Day Range
N/A
52-Week Range
$16.35
$19.50
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Nobel Biocare

NBHGF Stock News Headlines

The Gold Grab of the Century
When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.
Will There Be A Nobel Prize For AI?
The Gold Grab of the Century
When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.
What to Know About the 2023 Nobel Prizes
Nobel Economist Krugman Calls Out Venmo
See More Headlines
Receive NBHGF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nobel Biocare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/21/2014
Today
5/04/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Dental Equipment & Supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:NBHGF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
-0.01
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

NBHGF Stock Analysis - Frequently Asked Questions

How were Nobel Biocare's earnings last quarter?

Nobel Biocare Ag (OTCMKTS:NBHGF) announced its quarterly earnings data on Thursday, August, 21st. The company reported $0.17 earnings per share for the quarter, topping the consensus estimate of $0.12 by $0.05. The firm had revenue of $191.67 million for the quarter, compared to analyst estimates of $171.79 million.

This page (OTCMKTS:NBHGF) was last updated on 5/4/2024 by MarketBeat.com Staff

From Our Partners